After dealing with occasional heartburn for some time, Andrew sought medical advice when he began experiencing difficulty swallowing. This marked the beginning of a series of medical examinations and referrals that led to his diagnosis of oesophageal cancer. Recent data reveals a concerning trend in England, with the percentage of oesophageal cancer cases diagnosed at stage 4 rising from 25% in 2013 to 37% in 2022. Stage 4 cancer signifies an advanced stage where the disease has spread and is typically challenging to treat.
Individuals in the UK are being cautioned about persistent heartburn, which could potentially indicate oesophageal cancer, referred to as the “forgotten cancer” by Action Against Heartburn. This charity has examined the latest data on this form of cancer affecting the food pipe connecting the mouth to the stomach.
In 2023, Andrew Stanley received a stage 4 oesophageal cancer diagnosis, prompting his retirement to focus on battling the illness.
Reflecting on his experience, the grandfather of three shared, “I had been enduring heartburn for years without realizing its potential seriousness. It was only when I faced difficulties swallowing food that I sought medical attention. The diagnosis was a devastating revelation, especially learning that the cancer had already spread, limiting my life expectancy to around two years.
“Although relatively common, oesophageal cancer lacks adequate awareness. Recognizing symptoms is crucial, and I urge anyone relying on continuous heartburn medication to consult a doctor.”
Annually, approximately 9,200 new cases of oesophageal cancer are reported in the UK, with less than 20% of those diagnosed surviving beyond five years.
Jill Clark, chair of Action Against Heartburn, emphasized, “Oesophageal cancer is often overlooked, with a disproportionately high incidence in the UK. Late diagnosis frequently leads to fatal outcomes.”
Clark further explained, “The rise in late-stage diagnoses is likely influenced by various factors, including strain on the NHS, delays in referrals, unhealthy lifestyles, an aging population, and insufficient symptom awareness.”
The low survival rates associated with oesophageal cancer are primarily attributed to late detection. One-year survival rates for this cancer stand at 89% if diagnosed at stage 1 but drop significantly to 26% if diagnosed at stage 4.
Andrew shared, “Initially, treatment options were limited, but I was fortunate to participate in a clinical trial at Churchill Hospital in Oxford. The trial was highly successful, enabling me to undergo surgery and achieve cancer remission.
“I aim to inspire hope through my story while raising awareness about oesophageal cancer.”
At Reach and across our entities we and our partners use information collected through cookies and other identifiers from your device to improve experience on our site, analyse how it is used and to
